ResearchMedicine and treatment
Kidney decline nearly halted in a phase 3 trial — plus 2 more stories
3 stories this week: an immune kidney disease, sleep apnoea with excess weight and AI that reads chest scans, each with who was studied and where the evidence stops.
5 min read